Acurx Pharmaceuticals
(NASDAQ) ACXP
Acurx Pharmaceuticals Financials at a Glance
Market Cap
$10.73M
Revenue (TTM)
$0.00
Net Income (TTM)
$7.97M
EPS (TTM)
$-5.93
P/E Ratio
-0.63
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$3.71
Volume
250,277
Open
$3.92
Price
$3.71
Volume
250,277
Open
$3.92
Previous Close
$3.76
Daily Range
$3.55 - $3.96
52-Week Range
$1.33 - $21.00
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$3.71
Volume
250,277
Open
$3.92
Previous Close
$3.76
Daily Range
$3.55 - $3.96
52-Week Range
$1.33 - $21.00
ACXP News
ACXP: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Acurx Pharmaceuticals
Industry
Biotechnology
Sector
Health CareEmployees
4
CEO
David P. Luci, CPA
Website
www.acurxpharma.comHeadquarters
Staten Island, NY 10305, US
ACXP Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-271%
Return on Capital
-2%
Return on Assets
-1%
Earnings Yield
-1.59%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$10.73M
Shares Outstanding
2.85M
Volume
250.28K
Short Interest
0.00%
Avg. Volume
3.08M
Financials (TTM)
Gross Profit
$0.00
Operating Income
$8.09M
EBITDA
$8.09M
Operating Cash Flow
$6.79B
Capital Expenditure
$0.00
Free Cash Flow
$6.79B
Cash & ST Invst.
$7.56B
Total Debt
$0.00
Acurx Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$10.73M
N/A
Market Cap/Employee
$2.68M
N/A
Employees
4
N/A
Net Income
$1.58M
+43.3%
EBITDA
$1.62M
N/A
Quarterly Fundamentals
Net Cash
$7.56B
+203749.1%
Accounts Receivable
$48.42K
-5.3%
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-1.04%
N/A
Return on Invested Capital
-1.53%
N/A
Free Cash Flow
$4.58B
+203755.5%
Operating Cash Flow
$4.58B
+203755.5%